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6.1 Introduction
Congenital malformations are defects of the morphogenesis
of organs or body regions identified during intrauterine de-
velopment or at birth. They may be isolated and single, or
multiple. Their global birth prevalence is about 2−3%. Con-
genital defects may be caused by genetic and/or environmen-
tal factors, acting singly or in combination. Diagnostic and
therapeutic tools have allowed better identification of con-
genital malformations and have reduced long-term morbidity
and mortality in affected patients. Because of increased life
expectancy, congenital malformations today represent a major
issue in health care because of the resources needed for mul-
tidisciplinary care.
6.2 Classifications
Based on clinical criteria, major malformations are defined
as defects causing functional impairment and therefore need-
ing medical or surgical treatment. Defects that do not produce
functional impairment and do not require medical interven-
tion are termed minor malformations if their prevalence at
birth is less than 4% and phenotypic variants when the birth
prevalence is higher. Major and/or minor congenital malfor-
mations are frequently associated; apparently isolated defects
may be associated with malformations that are not clinically
evident at birth. 
On the basis of etiological criteria, it is possible to dis-
tinguish primary malformations, secondary malformations
(disruptions) and deformations (Table 6.1). Primary malfor-
mations are morphogenic defects arising from an intrinsic
error of development with a genetic origin. Disruptions occur
when an environmental factor interferes with an otherwise
normal developmental process, causing global impairment
or specific damage affecting a single developmental region.
The causes of secondary malformations may be biological,
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Table 6.1 Etiologic classification of congenital malformations
Primary (genetic) Secondary (environmental)
Chromosomal abnormalities
• Numeric
– polyploidy
– polysomy
– monosomy
• Structural
– deletions
– duplications
– insertions
– translocations
Monogenic
• Point mutations
– nonsense
– mis-sense
– frameshift
• Dynamic mutations
– triplet amplification
• Epigenetic regulation
– imprinting defects
– uniparental disomy
Polygenic
– oligohydramnios
– uterine malformations
Biologic agents
• Viruses
– cytomegalovirus
– rubella
– herpes viruses
• Bacteria
– Treponema pallidum
• Parasites
– Toxoplasma gondii
Chemical agents
• Drugs
– antiblastics
– anticonvulsants
– antibiotics
• Abuse substances
– alcohol
– smoke
– cocaine
– opiates
• Metabolic conditions
– hyperglycemia, hyperinsulinemia
– hyperphenylalaninemia
– hyperandrogenism
• Physical agents
– ionizing radiation
– electromagnetic radiation
• Vascular disruptions
– subclavian artery vascular
disruption
– twin-twin disruption sequence
• Mechanical causes (deformations)
– amniotic bands
– twinning
– uterine tumors
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chemical, metabolic, or physical. Deformations arise from
extrinsic mechanical compression of one or more regions of
the body during fetal development. The most common causes
of deformations are amniotic bands, twinning, uterine mal-
formations and masses.
Patients with multiple malformations can be classified as
having syndromes, sequences, associations, or dysplasias.
Syndromes are conditions where all the structural defects arise
from a single etiological factor, which may be genetic or en-
vironmental. Sequences are characterized by a cascade of dys-
morphic processes, linked by a cause/effect relationship with
a single initiating event. Thus, a primary defect may induce
several secondary defects, which are chronologically and
pathogenetically related. Associations are sporadic events
with different defects being present more frequently than
would be expected if they were random events, without evi-
dence of any etiological or pathogenetic relationship. In recent
years, some associations have been recognized as disorders
of blastogenesis, which are caused by genetic or environmen-
tal factors that interfere with early development when the em-
bryo is a single developmental field, and producing defects in
apparently unrelated organs and body regions. Blastogenesis
is the first 4 weeks after conception and is characterized by
processes that determine the midline and body axes, symme-
try and lateralization, neurulation and somite formation. Some
associations are identified by an acronym of the defects, such
as VACTERLS (Vertebral defects, Anorectal atresia, Cardiac
anomalies, Tracheoesophageal fistula, Esophageal atresia,
Renal anomalies, Limb defects, Single umbilical artery) and
CHARGE (Coloboma, Heart disease, Atresia of choanae, Re-
tarded mental development, Genital hypoplasia, Ear anom-
alies). Dysplasias are structural defects involving specific
tissues where a single gene mutation may determine the abo-
lition or reduction of protein synthesis as well as the produc-
tion of defective proteins.
6.3 Clinical Considerations
The birth of a baby with congenital malformations is the start-
ing point of a clinical process that is aimed at making a pre-
cise diagnosis [1, 2]. This leads to appropriate clinical
planning and definition of prognosis and counselling of the
parents. Different causal pathways may lead to a similar phe-
notype [3, 4] and the diagnostic process may be long and dif-
ficult, requiring follow-up to establish the natural history of
the disorder. The diagnostic process includes an accurate his-
tory, description of the phenotype, with appropriate imaging
and laboratory tests. Improvements in informatics have led
to the development of computerized systems to improve di-
agnostic accuracy. The history should include consideration
of the whole family (with the definition of a genealogical tree
and the identification of risk factors (consanguinity, multiple
abortions, stillbirths, advanced maternal and/or paternal age),
the preconceptional period and environmental factors (infec-
tions, maternal metabolic diseases, diabetes mellitus, drugs,
alcohol) and the pregnancy. Analysis of the phenotype is
aimed at the identification and description (with photographic
documentation) of structural defects (isolated and multiple,
major and minor) and should include a description of clinical
associations with genetic syndromes, such as neuropsy-
chomotor retardation, growth restriction, disorders of sexual
differentiation or pubertal development.
6.4 Genetic Counselling and Prenatal
Diagnosis
Genetic counselling is defined as the non-directive process of
communicating with and giving information to a family (usu-
ally the parents) to enable the making of decisions relating to
patients with genetic diseases that are considered, responsible
and rational. It is important that genetic counsellors have: (a)
a confirmed diagnosis for the index patient, (b) an up-to-date
knowledge of the natural history of the disease, (c) an under-
standing of its prognostic and therapeutic implications, (d)
knowledge of its pattern of inheritance, and (e) an awareness
of the possibilities for early (prenatal) diagnosis. The main
factors that determine a need for genetic counselling are the
presence of an index case with a congenital malformation or
of genetic disease in the family as well as the presence of
parental risk factors (consanguinity, advanced maternal age,
recurrent abortions, mutation carrier). If the disease is multi-
factorial (due to a combination of genetic and environmental
factors), a recurrence risk may be given only on the basis of
an empirical approach that takes account of the prevalence in
a certain population or at a certain maternal age, number of
affected subjects and consanguinity within the family. In the
case of monogenic diseases with Mendelian inheritance (au-
tosomal dominant, autosomal recessive, X-linked), the rela-
tive recurrence risk must be explained to the family, who must
also be informed about available opportunities for early diag-
nosis (preconceptional, prenatal, neonatal).
The recent identification of complex genetic mechanisms
(genomic imprinting, uniparental disomy, triplet amplifica-
tion) has increased the number of diseases in which is pos-
sible to give helpful genetic counseling. 
6.5 Associations
Associations are usually sporadic conditions with a low re-
currence risk. Environmental factors (alcohol, drugs, maternal
diabetes) as well as chromosomal and single gene disorders
may interfere with the blastogenic processes. A genetic back-
ground may also increase an individual’s susceptibility to en-
vironmental factors
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6.5.1 VACTERLS Association
Characterised by the manifestation of some or all of the defects
summarized by the acronym: Vertebral defects, Anorectal atre-
sia, Cardiac anomalies, Tracheoesophageal fistula, Esophageal
atresia, Renal anomalies, Limb defects, Single umbilical artery.
Tracheoesophageal and anorectal defects require early surgery
during the neonatal period. The most frequent heart defects af-
fect the ventricular septum. Limb defects include radial ray ab-
normalities (radial hypoplasia, thumb aplasia or hypoplasia as
well as its duplication), polydactyly and syndactyly. Other fea-
tures may be prenatal and postnatal growth restriction, ear and
external genitalia abnormalities. VACTERLS association is
often sporadic with a low recurrence risk. It is more frequent
in the offspring of diabetic mothers. In some patients with as-
sociated obstructive hydrocephalus, gene mutations with
Mendelian inheritance have been documented. Most patients
have normal cognition, although they may present as failure
to thrive and with neuromotor disabilities.
6.5.2 Infants of Diabetic Mothers
Congenital malformations in the offspring of diabetic mothers
are clinically heterogeneous. Their frequency is 2−4 fold
higher than in the general population. The relative risk for mal-
formations is much higher in newborns of women with type I
insulin-dependent diabetes mellitus and is inversely correlated
with the effectiveness of maternal glycemic control, particu-
larly during the periconceptional period. Several factors are
involved in the pathogenesis of such defects: hyperglycemia,
hyperglycosylation of proteins involved in differentiation,
chronic hypoxia, polycythemia/hyperviscosity, and lactic aci-
dosis. All these factors may interact and interfere with blasto-
genesis, inducing abnormalities of the midline structures and
symmetric organs. All types of malformations (skeletal, car-
diac, renal, gastrointestinal, CNS) are more common in the in-
fants of diabetic mothers. Some are specific, such as caudal
dysgenesis, characterized by defects of vertebral, urogenital
and intestinal structures arising from the caudal mesoderm,
with a wide spectrum of expression including sirenomelia, in
which there is also a complex vascular defect. The fetus may
be macrosomic because of fetal hyperinsulinemia, although a
placental microangiopathy may also cause intrauterine growth
restriction. 
6.6 Sequences
Malformation sequences may be caused by genetic as well as
environmental factors. Several organs and systems may be
involved in malformation sequences (Table 6.2).
6.6.1 Holoprosencephalic Sequence
Holoprosencephalic sequence presents at birth with a wide
spectrum of defects of the encephalon and the median cran-
iofacial areas due to a developmental defect of the median
subdivision of the prosencephalic vesicle and surrounding
mesoderm. It is characterized by a wide range of etiological
factors, being found in patients with chromosomal aberra-
tions, monogenic mutations and environmental disruptions
(gestational diabetes, cytomegalovirus).
Three anatomical variants (alobar, semilobar and lobar)
and four clinical variants (cyclopia, ethmocephaly, cebo-
cephaly and premaxillar agenesis) have been described. Clin-
ical evaluation must include CNS imaging to define the full
phenotype. The severity of CNS defects is the main reason
for the high and early lethality of the condition. If the pheno-
type is only partially expressed, longer survival is possible,
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Table 6.2 Main malformation sequences
Name Developmental field and organs involved
Holoprosencephaly Precordial mesoderm, prosencephalic vesicle, rinencephalon, orbits, nose, premaxilla
Septo-optic dysplasia Optic chiasm, hypophysis
Pierre Robin Jaw bone, oro-pharyngeal region
DiGeorge 4th brachial arch, 2nd and 3rd brachial pouches
Poland Pectoral muscle, superior limb
Klippel-Feil Spine
Potter Kidneys, urinary tract, lungs, limbs, facies
Prune belly Urinary tract, abdominal wall
Bladder-cloacal extrophy Peri-umbilical mesoderm
Rokitanski Muller ducts
Sirenomelia Caudal mesoderm
Caudal regression Caudal mesoderm
Premature rupture of amnion Median axis, limb deformations, facial clefts
Fetal akinesia Multiple body regions
Twin-twin disruption sequence Multiple body regions
frequently associated with relevant neurologic problems. The
parents and relatives of patients must be investigated for minor
signs of the sequence (hypotelorism, single median incisor) in
order to recognize a possible autosomal dominant inheritance.
Most cases are multifactorial and the recurrence risk for fam-
ilies with a sporadic case is estimated at around 6%.
6.6.2 Pierre Robin Sequence
Pierre Robin sequence is a developmental defect of the
mandible and surrounding oro-pharyngeal region. It is char-
acterized by microretrognathia, cleft palate and functional
disturbances (swallowing deficit, respiratory distress). A de-
ficiency of mesoderm induction may cause a primary cleft
palate (V-shape). Alternatively, the cleft palate may be sec-
ondary to jaw arch hypoplasia, which leads to the position of
the tongue being fixed between the palatine processes, caus-
ing a defect of fusion of the secondary palate in the midline
(U-shape). Respiratory obstruction is caused by the tongue
falling backwards and by a primitive pharyngeal stenosis
(secondary to a migration deficit of neural crest cells). The
sequence may present with a wide phenotypical spectrum, ei-
ther in isolation or as part of a more complex syndrome (del
18q, Stickler syndrome). All these variables influence the
prognosis. Newborns may require prolonged respiratory
and/or nutritional support, long-term hospitalization and fol-
low-up. In the most severely affected cases, surgery to the
jaw distraction may improve the outcome.
6.6.3 Potter Sequence
The Potter sequence is caused by absent or severely reduced
fetal urine output from the first trimester. It may be secondary
to bilateral renal agenesis (a differentiation defect of the
metanephric blastema) or to other renal and urinary tract mal-
formations. The cascade mechanism starts with diminished
urine production by the fetus; this leads to a reduced volume
of amniotic fluid (anhydramnios or oligohydramnios), which
give rise to pulmonary hypoplasia, leading to respiratory dis-
tress at birth, facial dysmorphism (prominent nose and flat
profile), diminished fetal movements with multiple postural
deformations particularly of the lower limbs. When the phe-
notype is fully expressed, the severe renal and pulmonary
damage is responsible for the high perinatal mortality. Prenatal
diagnosis by ultrasound reveals the kidney defect, oligohy-
dramnios and other associated malformations. The sequence
is often sporadic, with etiological heterogeneity and a recur-
rence risk of about 3%. It may occasionally be associated with
other defects in a more complex syndrome (Meckel-Gruber
syndrome: occipital encephalocele, renal cystic disease, poly-
dactyly and an autosomal recessive inheritance).
6.6.4 Prune Belly Sequence
This sequence was named because of the characteristic ap-
pearance of the abdomen (wrinkled skin, also referred to as
“flabby abdomen”) in the affected newborns. The sequence
may be related to various defects of the genitourinary tract,
involving the proximal urethra (urethral agenesis, cloacal per-
sistence, urethral stenosis, posterior urethral valves in males)
[5]. Urethral obstruction is responsible for oligohydramnios
(and possible secondary Potter sequence) and accumulation
of urine in the proximal renal tract, leading to parenchymal
damage (bladder dilatation, bilateral ureteric dilatation and
hydronephrosis). Bladder hypertrophy and dilatation may in-
terfere with development of the abdominal wall muscles, di-
aphragm and testicular migration in the scrotum in males
(cryptorchidism). Abdominal wall muscle hypoplasia is re-
sponsible for the prune belly appearance because of visible
intestinal loops through the thin abdominal wall. Diaphrag-
matic defects and oligohydramnios cause lung hypoplasia
and severe respiratory distress at birth. Although early pre-
natal diagnosis by ultrasonography is possible, the differen-
tial diagnosis between isolated renal cystic conditions and
obstructive uropathies may be difficult. Prenatal bladder
catheterisation allows urine to flow into the amniotic cavity
and must be followed by surgical correction after birth. 
6.7 Syndromes
6.7.1 Chromosomal Abnormalities
The overall incidence of chromosomal anomalies is estimated
at about 1:170 live births. Their prevalence at conception is
much higher, giving rise to a spontaneous abortion or fetal
death because of developmental impairment. About 50% of
spontaneous abortions have an abnormal chromosomal struc-
ture. Chromosomal aberrations may affect autosomes and/or
sex chromosomes and may involve their number or structure.
Numeric aberrations have a prezygotic origin (meiotic non-
disjunction, frequently related to advanced maternal age).
They may also arise from a postzygotic error when they are
present only in a variable proportion of cells (mosaics). Struc-
tural aberrations may occur de novo from a meiotic re-
arrangement or may be inherited from one parent, who carries
a balanced non-symptomatic chromosomal translocation.
6.7.1.1 Down Syndrome (Trisomy 21)
Down syndrome is the most frequent chromosomal aberration
at birth (about 1:700). It is determined by a trisomy of chro-
mosome 21. In most (95%) cases, trisomy 21 is secondary to a
maternal meiotic non-disjunction of homologous chromosomes
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21, more rarely there may be a Robertsonian translocation or
a post-zygotic mitotic non-disjunction (mosaic with milder
phenotype). The incidence is related to maternal age at con-
ception (1/1500 at 20 years and 1/28 at 45 years). Overall re-
currence risk is low (about 1%), although it significantly
increases when one of the parents carries a balanced translo-
cation. The phenotype at birth is characteristic: main facial
features are Brushfield spots (grey spots in the median zone
of the iris), upslanting palpebral fissures, epicanthal folds,
small nose, small mouth with prominent tongue, flat facial
profile, brachycephaly with a flat occipital bone, small low-
set ears, short neck with redundant skin folds. Newborn babies
are hypotonic with lax joints. A single palmar crease and clin-
odactyly of the little finger are frequent. Organ involvement
includes congenital heart defects (atrioventricular canal, ven-
tricular septal defects, tetralogy of Fallot), duodenal atresia or
stenosis, Hirschsprung’s disease, hypothyroidism and urinary
tract malformations. Long-term follow-up is required because
of psychomotor and mental retardation, growth retardation,
occurrence of autoimmune diseases, immunodeficiencies and
leukemia. Survival rates and the quality of life have improved
significantly with educational and screening programs and the
development of multidisciplinary follow-up.
6.7.1.2 Edwards Syndrome (Trisomy 18)
Edwards syndrome is determined by trisomy of chromosome
18, sometimes as a mosaic or in association with other chro-
mosomal abnormalities. Its birth prevalence is about 1:8000
because most affected fetuses abort spontaneously. Newborns
show severe prenatal growth restriction, dolicocephaly with
prominent occiput and low-set dysplastic external ears, jaw
hypoplasia, flexed hands with the index finger overlapping
the middle finger, single palmar crease, and talipes with
rocker-bottom feet. There are frequently associated malfor-
mations (heart, renal, intestinal, CNS), which are responsible
for the very grave prognosis and high neonatal mortality.
6.7.1.3 Patau Syndrome (Trisomy 13)
Determined by trisomy of chromosome 13, sometimes with
chromosomal translocation, or rarely as mosaic. Its birth
prevalence is about 1/10,000. Newborns show prenatal growth
restriction, a small trigonocephalic skull, areas of aplasia cutis
on the scalp, cleft lip and palate, microphthalmia, variable
hypotelorism up to cyclopia (i.e., expression of an associated
holoprosencephalic sequence), postaxial polydactyly and/or
syndactyly, forced flexion of the fingers, single palmar crease,
plantar convexity, and cryptorchidism. Other organs are fre-
quently involved (heart, kidneys). Patients with fully ex-
pressed phenotype usually die during the first month of life,
those with milder signs (mosaics) may survive with severe
developmental deficits.
6.7.1.4 Wolf-Hirschhorn Syndrome (4p-)
This is a rare condition determined by deletion of the distal
part of the short arm of chromosome 4. Newborns present
with prenatal growth restriction, hypotonia, severe micro-
cephaly with brachycephaly, prominent nose, downturned
corners of the mouth, arched palate, jaw hypoplasia, hyper-
telorism, downslanting palpebral fissures, iris coloboma,
large low-set external ears. Heart, renal and skeletal defects
are frequent. The degree of extension of the chromosomal
deletion influences the severity of phenotype and neonatal
mortality rate. Surviving patients show severe postnatal
growth retardation and psychomotor developmental delay.
6.7.1.5 Cri-du-chat Syndrome (5p-)
Cri-du-chat syndrome is due to a variable deletion of the short
arm of chromosome 5. Named because of the characteristic
high-pitched cat-like cry of affected newborns caused by hy-
poplasia of laryngeal cartilages, which disappears after the
first months of life. Other phenotypical features are micro-
cephaly, round face, hypertelorism, micrognathia, epicanthal
folds, low-set ears. At birth there is generalized hypotonia.
Later there is limb hypertonia and severe psychomotor and
mental retardation.
6.7.1.6 Mosaic 8 Chromosome Trisomy
The full trisomy of chromosome 8 is extremely rare in hu-
mans. It is more common as a mosaic. The phenotype of mo-
saic trisomy 8 includes scaphocephaly, ankylosed large joints,
clubfoot, absent or hypoplastic patellae, arachnodactyly and
brachydactyly. Deep grooves in the palms and soles (Fig. 6.1)
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Fig. 6.1 Deep plantar grooves in a newborn with mosaic 8 chromo-
some trisomy
are virtually diagnostic in infancy but become less prominent
with age. The face is characterized by a prominent pouting
lower lip and small jaw. Mental retardation may be present
but is often mild and may remain undetected. 
6.7.1.7 Turner Syndrome
Turner syndrome is the most frequent aneuploidy of sex chro-
mosomes with a birth prevalence of 1/2500. It is determined
by a monosomy of chromosome X, which may be complete
(50%) or partial (20%); it frequently presents as a mosaic
with a milder phenotype (30%). During the neonatal period,
the diagnosis is suspected because of lymphedema of the
hands and feet (Fig.6.2), nail dysplasia, neck pterygium, a
large mouth with downturned corners, dysplastic external ears
and left heart output defects (aortic coarctation, left heart hy-
poplasia). In addition, there may be a prenatal history of cys-
tic hygroma. The clinical phenotype changes with age when
other features become evident: short stature, short neck, low
posterior hairline, restricted thorax, cubitus valgus, shortness
of the fourth metacarpal bone, primary amenorrhea, absence
of secondary sexual signs, an endocrine profile of gonadal
dysgenesis. Life expectancy is not reduced, but long-term fol-
low-up is required and appropriate hormonal therapy (growth
hormone in the first decade and oestrogen-pregesterone after
puberty must be given in order to improve height and induce
the menstrual cycle.
6.7.1.8 CATCH 22 Syndrome
CATCH 22 is an acronym of the main clinical features (Car-
diac abnormality, Abnormal face, Thymic hypoplasia, Cleft
palate, Hypoparathyroidism, chromosome 22 microdeletion).
This syndrome combines some clinical conditions which
were previously described separately (Velo-Cardio-Facial
syndrome, Di George sequence). It is due to a deletion of the
chromosomal region 22q11.2. Clinical expression is variable
and FISH analysis is required to confirm the diagnosis and
to define the extent of deletion and the genes involved (con-
tiguous gene syndrome) [6]. Heart defects are conotruncal
(aortic arch interruption, common arterial trunk, tetralogy of
Fallot). When the brachial structures are involved, there is
dysfunction of the immune system (T-cell deficiency) and
parathyroidal abnormalities with low serum calcium levels.
During the neonatal period, the full expression of the phe-
notype results in hypocalcemia and craniofacial dysmor-
phism (micrognathia, cleft palate, anteverted nares, low-set
external ears) with a conotruncal heart defect and absent
thymic shadow at chest X-ray delineating the phenotype with
full expressivity.
6.7.2 Monogenic Disorders
Monogenic disorders are single gene mutations with a
Mendelian mode of inheritance. The genotype-phenotype
correlation remains undefined for many conditions. Each
syndrome may be due to different mutations in the same gene
or in different genes (genetic heterogeneity). The same mu-
tation may determine different phenotypes (phenotypical
variability) in the same family and appears to depend on in-
terference by other genetic and/or environmental factors. In
addition, epigenetic factors (e.g., DNA methylation) may act
during the differentiation processes to modify gene expres-
sion and may depend on the parental origin of the gene (ge-
nomic imprinting).
6.7.2.1 Cornelia de Lange Syndrome
Affects 1/10,000 newborns and is usually sporadic due to de
novo mutations (gene locus at 5p13.1 encoding for the
NIPBL protein) [7]. Newborns show a typical facial appear-
ance (microbrachycephaly, low anterior and posterior hair-
line, synophrys, small nose with a depressed nasal bridge,
anteverted nares, long philtrum, “carp” mouth, maxillary
prognathism, low-set ears) (Fig. 6.3), with intrauterine and
postnatal growth retardation, hypertrichosis and upper limb
anomalies (small limbs, reduction defects including pho-
comelia, limited elbow extension, single palmar crease, oly-
gosyndactyly).
Urogenital, heart and intestinal malformations may also
be present. All patients have psychomotor and growth retar-
dation. Infections, feeding difficulties and neurologic distur-
bances (seizures, motor and speech retardation) require
long-term multidisciplinary follow-up and family support.
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Fig. 6.2 Foot lymphedema in a baby with Turner syndrome
6.7.2.2 Rubinstein-Taybi Syndrome
A rare sporadic syndrome characterized by mental retarda-
tion, facial abnormalities, broad thumbs and toes. There is ge-
netic heterogeneity and about 25% of patients present with
mutations or microdeletions in the gene encoding the tran-
scriptional coactivator CREB-binding protein (16p13.3) [8].
Familial cases with autosomal dominant inheritance have
been described. The main craniofacial features (Fig. 6.4) are
microcephaly, frontal bossing, large anterior fontanelle,
downslanting palpebral fissures, broad nasal bridge, beaked
nose, epicanthal folds, strabismus, maxillary hypoplasia, high
arched palate, external ear abnormalities. There is hand and
foot involvement (broad distal phalanges of thumbs and hal-
luces with medial deviation, clinodactyly or duplication).
There may also be hirsutism and abnormalities of the skeleton
(spinal, pelvic), heart (septal defects, patent ductus arteriosus)
and urogenital tract (hypospadias, cryptorchidism). Growth
retardation, skeletal maturation delay and severe mental re-
tardation are more common with increasing age.
6.7.2.3 Marfan Syndrome
A congenital defect of connective tissue involving the skele-
ton, eye and cardiovascular system. It is determined by het-
erozygous mutations in the FBN1 gene (15q21.1) encoding
for fibrillin 1 protein, which is a component of collagen [9].
It is inherited as an autosomal dominant with variable clinical
expression; about 25% of cases are sporadic, due to de novo
mutations correlated with advanced paternal age. Newborns
show arachnodactyly, long and thin limbs, increased length
joint laxity and hypermobility, muscular hypotonia, hernias,
pectus carinatum or excavatum. Cardiac abnormalities com-
prise mitral valve prolapse and aortic defects (aortic root di-
latation and aortic aneurysm). Patients with most severe
neonatal phenotype (neonatal Marfan syndrome) have high
early mortality rates. Skeletal and cardiac problems usually
evolve with growth (kyphoscoliosis, progressive aortic dilata-
tion, aortic dissection) and ocular signs develop (ectopia
lentis, early glaucoma). 
6.7.2.4 Noonan Syndrome
Noonan syndrome is a relatively frequent (1/2000) condition
with some phenotypic features similar to those of Turner syn-
drome (male Turner, pseudo-Turner). It is due to mutations in
the PTPN11 gene (12q24.1), with sporadic as well as familial
cases [10]. The inheritance is autosomal dominant and parents
must be always investigated for mild clinical signs. Newborns
show hypertelorism, upslanting palpebral fissures, low-set
posteriorly rotated ears, neck pterygium, a shield chest with
deformation of the sternum, and lymphedema (Fig.6.5). Car-
diac involvement is mainly of the pulmonary outflow tract
(pulmonary valve dysplasia and stenosis, cuspid thickening
and hypomobility). Other possible features are cryptorchidism
in males and a bleeding tendency, due to thrombocytopenia
and partial deficiency of coagulation factors. Later in infancy,
other signs become evident: postnatal growth retardation (with
short stature and retarded bone age), triangular face, mild psy-
chomotor and intellectual retardation. Life expectancy de-
pends exclusively on the severity of heart manifestations.
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Fig. 6.3 Typical facial appearance of a newborn baby with Cornelia de
Lange syndrome, showing synophrys, a depressed nasal bridge, antev-
erted nares, long philtrum, carp mouth
Fig. 6.4 Newborn with Rubinstein-Taybi syndrome showing micro-
cephaly, frontal bossing, downslanting palpebral fissures, broad nasal
bridge, beaked nose, epicanthus, maxillary hypoplasia
6.7.2.5 Prader-Willi Syndrome (PWS)
Determined by the failure of expression of genes of paternal
origin in the 15q11-q13 region. These genes are normally sub-
jected to maternal imprinting (DNA methylation) which
avoids maternal copy transcription and determines a func-
tional gene monosomy (only the paternal copy is expressed).
This condition may arise from microdeletions of paternal
chromosome 15 (70%), maternal uniparental disomy
(25−30%) or imprinting center defects. Methylation testing
identifies almost all patients; FISH and microsatellite DNA
analysis may reveal microdeletions and maternal UPD. PWS
newborns (Fig. 6.6) present with congenital hypotonia, a pre-
natal history of reduced fetal movements, poverty of facial
expression, dolicocephaly with reduced bitemporal diameter,
almond-shaped eyes with upslanting palpebral fissures, a
small mouth with downturned corners and thin upper lip,
small hands and feet and genital hypoplasia with cryp-
torchidism in males [11]. Hypotonia of the respiratory, oro-
facial and pharyngoesophageal muscles cause variable
degrees of respiratory and feeding difficulties (poor suction
and swallowing), which are present from birth and tend to
improve after the neonatal period. After the first year of life,
the phenotype modifies and is characterized by hyperphagia,
obesity, sleep disturbances, short stature, hypogonadotropic
hypogonadism, mild to moderate mental retardation, speech
delay. Treatment with growth hormone (GH) is possible and
good clinical results have been reported.
6.7.2.6 Beckwith-Wiedemann Syndrome (BWS)
A sporadic condition determined by an altered balance be-
tween cooperating genes in the region 11p15. The genetic
mechanism is complex and involves imprinted genes encoding
for several important growth factors and receptors. Various
genotypic abnormalities have been described in BWS patients,
e.g., microduplication of paternal region 11p15, microdeletion
of the maternal region, and mutations and paternal uniparental
disomy of chromosome 11. The main neonatal clinical features
(Fig. 6.7) are exomphalos, macroglossia and gigantism (EMG
syndrome). Other features are visceromegaly, adrenocortical
cytomegaly, dysplasia of the renal medulla, typical linear in-
dentations of the helix and the auricular lobe of the ear, hypo-
glycemia during the first days of life, limb hemihypertrophy.
Prenatal diagnosis may be because of exomphalos and gener-
alized overgrowth seen on ultrasound scanning. The neonatal
diagnosis is based on clinical findings, although careful mo-
lecular cytogenetic analysis of the 11p15 region is recom-
mended. Overgrowth and macroglossia tend to become less
evident with age, but there is an increased risk of malignant
tumors (Wilms’ tumor, adrenal carcinoma, hepatoblastoma). 
6.7.2.7 Silver-Russell Syndrome
Silver-Russell syndrome is a sporadic condition with genetic
heterogeneity. Various genetic loci have been involved [12].
In some patients it is caused by hypomethylation at distal chro-
mosome 11p15 (the opposite of patients with Beckwith-
Wiedemann syndrome). In others, it is related to a maternal
uniparental disomy of chromosome 7. The neonatal phenotype
is characterized by severe intrauterine growth restriction with
normal development of the skull (pseudohydrocephalic ap-
pearance), poor postnatal growth, craniofacial features (trian-
gular shaped face and broad forehead), body asymmetry and
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Fig. 6.5 A patient with Noonan syndrome with hypertelorism, upslant-
ing palpebral fissures and shield chest
Fig. 6.6 The neonatal phenotype of Prader-Willi syndrome: hypomimic
face, reduced bitemporal diameter, almond-shaped eyes, small mouth
with downturned corners and thin upper lip
a variety of minor malformations (clinodactyly and syndactyly
of the little finger). The phenotypic expression changes during
childhood and adolescence, with the facial features and asym-
metry usually becoming more subtle with age. GH therapy
should be considered to improve final height.
6.7.2.8 Goldenhar Syndrome (GS)
Goldenhar syndrome is a spectrum of malformations involv-
ing the eye, ear and vertebrae with heterogeneous etiology and
a highly variable phenotype [13]. Its prevalence at birth is
about 1/5000. Most cases are sporadic, although some families
with autosomal dominant inheritance have been described. GS
originates from a vascular disruption of the first and second
branchial arches, with consequent malformations of related
organs and tissues. Defects are more often unilateral and an
increased incidence has been reported in the offspring of dia-
betic mothers, as have other disorders of blastogenesis. GS
newborns show multiple craniofacial anomalies (Fig. 6.8):
hemifacial microsomia, ipsilateral deformity of the external
ear (preauricular tags, atresia of the external auditory canal,
anomalies in size and shape of the external auricle), epibulbar
dermoid, coloboma of the upper eyelid. In addition, defects of
the cervical vertebrae (hemivertebrae, fusions, segmental age-
nesis), cleft palate, choanal athresia, heart, kidney and CNS
defects may be found. Auditory function must be assessed
early to preserve speech and cognitive development. 
6.7.2.9 Smith-Lemli-Opitz Syndrome (SLOS)
A rare (1/30,000) autosomal recessive condition, caused by
mutations in the gene encoding steroid delta-7-reductase,
which maps to the region 11q12-q13 [14]. The enzyme defi-
ciency causes a severe deficit of endogenous cholesterol pro-
duction and its derivative compounds (sexual steroids,
components of the myelin and cellular membranes), starting
from intrauterine life. SLOS newborns show intrauterine
growth restriction, severe hypotonia, microdolicocephaly,
high forehead, palpebral ptosis, anteverted nares and microg-
nathia. There may be other features, such as agenesis of the
corpus callosum, cleft palate, syndactyly of second and third
toes, congenital heart defects, liver dysfunction. Male patients
usually have hypospadias, micropenis, cryptorchidism and
sometimes various degrees of ambiguous genitalia, because
of the prenatal androgen deficiency. There are low cholesterol
and elevated 7-dehydrocholesterol levels in the blood. The
underlying mutation is identified by gene sequence analysis,
which allows confirmation of the prenatal diagnosis for at-
risk couples. Failure to thrive worsens with age and there is
always severe psychomotor delay. Patients may be helped by
exogenous cholesterol supplementation, particularly for the
biliary acid profile.
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Fig. 6.7 Exomphalos, macroglossia and gigantism
Fig. 6.8 Hemifacial microsomia and atresia of external auricle in a baby
with Goldenhar syndrome
6.8 Disruptions
Some congenital malformations can be related to exogenous
factors, which act during intrauterine life, inducing abnormal-
ities of developmental and differentiation processes. The most
susceptible period is the first trimester of pregnancy in which
the identification of developmental fields, organogenesis and
differentiation take place. Biological, chemical, metabolic,
physical and mechanical agents (Table 6.1) may cause defects
of morphogenesis. The etiologic identification is important
for effective genetic counselling and reducing the risk of re-
currence in an affected family. 
6.8.1 Biologic Agents
Most morphogenetic defects determined by biological agents
are pathogenetically and clinically characterized. A high IgM
level soon after birth is strongly suggestive of a prenatal in-
fection of the fetus, although only 30% of these newborns
show clinical consequences. The earlier the timing of intrauter-
ine infection (particularly during the first trimester of gesta-
tion), the more severe is the effect of morphogenetic defects
due to viral and bacterial agents and there is usually associated
intrauterine growth restriction. The most common embryofe-
topathies due to biologic agents are described in Table 6.3.
6.8.2 Chemical Agents
Any substance introduced to the human organism can be con-
sidered as a chemical agent. They may be drugs or foods as-
sociated with flawed lifestyle choices (alcohol consumption,
cigarette smoking, ingestion of substances of abuse) or pro-
duced by maternal metabolism in specific situations. Some
drugs and single molecules, which are well tolerated by an
adult, may be seriously dangerous for the development of the
embryo and fetus. Drug testing in human pregnancy is diffi-
cult and all drugs have therefore to be considered potentially
harmful, requiring careful risk/benefit evaluation. Substances
may cross the placenta and reach the fetus and placental func-
tion may reduce or increase their effects. Individual metabo-
lism may influence the clinical effects, dosage and timing of
administration. The most frequent disruptions by chemical
agents are reported in Table 6.4.
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Table 6.3 Main disruptions determined by biologic agents
Biologic agent Phenotype
Cytomegalovirus Microcephaly, intracranial calcifications, psychomotor delay, sensorineural hearing loss, chorioretinitis,
hepatosplenomegaly, thrombocytopenia, virus presence in secretions and biologic fluids (urine)
Rubella virus Microcephaly, psychomotor delay, congenital cataract, sensorineural hearing loss, heart defects, hematologic alterations
(anemia, thrombocytopenia)
Varicella-zoster virus Mental retardation, cortical atrophy, seizures, chorioretinitis, skin scars
Treponema pallidum Palmoplantar pemphigus, exanthema with skin scars, anemia, thrombocytopenia, hepatosplenomegaly, myocarditis,
chorioretinitis, muco-hematic rhinitis, skeletal alterations (lacunae, caput quadratum, metaphyseal ossification defects,
osteochondrites and secondary pseudoparalysis)
Toxoplasma gondii Hydrops, hydrocephalus, intracranial calcifications, chorioretinitis, cataract, seizures, hepatosplenomegaly, skin rush
Table 6.4 Main disruptions determined by chemical agents
Chemical agent Phenotype
Anticonvulsant drugs Cleft lip and palate, neural tube defects, congenital heart defects
– hydantoin (microcephaly, mental retardation, CNS abnormalities, small nose, facial bone hypoplasia, epichantus,
hypertelorism, strabismus, cleft lip and palate, micrognathia, short neck, heart defects)
– trimethadione (microcephaly, facial bone hypoplasia, palpebral synophrys, epicanthus, external ear dysplasia,
urogenital defects, heart defects)
– valproic acid (trigonocephaly, reduced bitemporal diameter, facial bone hypoplasia, small nose, cleft lip and palate,
urogenital and limb defects)
Alcohol IUGR, peculiar face (microcephaly, short palpebral fissures, small nose with anteverted nares, hypoplastic nasal philtrum,
microretrognathia), neurologic abnormalities (hypotonia, seizures, poor motor coordination, mental retardation)
Cocaine Prematurity, IUGR, microcephaly, urogenital and skeletal malformations
Heroin IUGR, low birth weight, congenital malformations
Maternal diabetes Macrosomia, hypoglycemia, hypocalcemia, ventricular septal hypertrophy, caudal dysgenesis, any kind of congenital
malformations (skeletal, cardiac, renal, intestinal, CNS, etc.)
Maternal Defects of cellular proliferation and migration with myelinization delay (IUGR, severe microcephaly, hypotelorism,
hyperphenylalaninemia prominent nose, low-set dysplastic external ears, mental retardation, cleft lip and palate, conotruncal heart defects)
6.8.3 Vascular Disruptions
Any vascular accident during early embryonic and fetal de-
velopment may determine subsequent morphogenetic defects
in the relevant body region. 
Disruption of the subclavian artery includes a heteroge-
neous group of clinically and etiologically different condi-
tions, characterized by alteration of different mesodermal
structures supplied by the subclavian artery. Thus, the Poland
sequence includes pectoral muscle agenesis and ipsilateral
superior limb reduction defects. Kidney and urinary tract de-
fects are frequently associated, expanding the phenotype to-
wards an acro-pectoral-renal developmental field. 
Twin-twin disruption sequence (TTDS) may involve var-
ious structures such as the brain, brachial arches, limbs, gut,
and kidneys. It is caused by the intrauterine developmental
impairment and subsequent death of a monozygotic twin. The
presence of vascular placental anastomoses between the ar-
terial supplies of twins and abnormal communicating flow al-
lows the passage of thromboemboli to the surviving twin,
with reduced or interrupted blood flow causing structural
damage. The complex vascular interactions between monozy-
gotic twins may result in other vascular disruptions (e.g., be-
cause of an acardic twin) or a twin-twin transfusion sequence,
which are particular features of monozygotic twins.
6.9 Dysostoses 
A heterogeneous group of birth defects with single or multiple
involvement of skeletal segments (with no systemic cartilagi-
nous tissue involvement), due to mutations of the genes in-
volved in bone development. Dysostoses classification is
based on phenotypic criteria and the body region most in-
volved. In some instances a genetic classification is now pos-
sible. Most syndromal craniosynostoses are determined by
mutations in fibroblast growth factor receptor (FGFR) genes,
with string evidence of genetic heterogeneity (the same con-
dition being determined by different mutations in the same
gene or in different FGFR genes) and genetic pleiotropism
(the same mutation being responsible for different pheno-
types). Genotype/phenotype correlation is not possible for all
cases and it can be influenced by other genes (epistatic) as well
as other interactive cytoplasmic and environmental factors.
6.9.1 Craniofacial Dysostoses
Full fusion of all cranial sutures is normally achieved at about
25 years of age. Craniosynostoses depend on a precocious clo-
sure of one or more cranial sutures and may cause a restriction
in the size of the cranium. The closure of a suture limits cra-
nial growth at that site and there is increased cranial growth
at the other sutures, producing deformation of the skull (some-
times with brain growth restriction, hydrocephalus, and in-
tracranial hypertension). Skull morphology depends on suture
involvement (nature, timing, extension and symmetry). The
overall incidence of craniosynostoses is estimated to affect
about 1/3000 newborns. It may present in isolation or as part
of a more complex syndrome.
6.9.1.1 Non-Syndromal Craniosynostoses
Scaphocephaly depends on the premature fusion of the sagit-
tal suture with consequent restriction of growth along the
transverse axis and compensatory increased growth along the
antero-posterior axis. Plagiocephaly depends on the prema-
ture fusion of a single coronal suture with consequent ipsilat-
eral growth restriction and flattening of the frontal bone; the
involvement of facial structures varies from simple deviation
of nasal septum to severe asymmetry of the sphenoid and
maxillary bones. Brachycephaly is due to premature fusion
of both coronal sutures with consequent growth restriction
along the antero-posterior axis and compensatory increase in
skull height; hypoplasia of the frontal region is often present.
Acrocephaly depends on the premature fusion of the coronal
and sagittal sutures with consequent severe growth restriction
along both antero-posterior and transverse axes and compen-
satory increased development of the frontal region. Intracra-
nial hypertension is frequently present and requires early
surgical correction to avoid severe CNS complications.
Trigonocephaly is due to the premature fusion of the metopic
suture, often evident because of a longitudinal bone crest in
the median frontal region, giving the skull a triangular ap-
pearance with hypotelorism and flattening of the lateral
frontal regions. Cloverleaf skull is due to the premature fusion
of the coronal, sagittal and lambdoideal sutures with exces-
sive skull growth in height and to both sides, giving a trilobar
appearance. Intracranial hypertension is consistently severe
and gives rise to CNS complications.
6.9.1.2 Syndromal Craniosynostoses
Apert syndrome is a rare and serious phenotype described in
newborns with acrocephaly and syndactyly of the hands and
feet (Fig. 6.9). The premature fusion of both coronal sutures
is responsible for acrocephaly, frontal bossing, flat occipital
bone, facial dismorphic features (downslanting palpebral fis-
sures, exophthalmus, hypertelorism, small upturned nose,
maxillary hypoplasia, low-set ears). Hands and feet present a
complete syndactyly (spoon shaped hand) with bone and nail
fusion. Synostosis may also found in the carpal and tarsal
bones and cervical vertebrae. Mental retardation may be
present, as well as intracranial hypertension, particularly in
absence of early neurosurgical correction. A complex surgi-
cal program must be planned for the correction of multiple
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synostosis (skull remodelling, hand surgery). Apert syndrome
is due to mutations in the exon 7 of the FGFR2 gene (different
mutations have been identified), with autosomal dominant in-
heritance and a high rate of de novo mutations correlated with
advanced paternal age [15].
Crouzon syndrome is the most frequently reported syn-
dromal craniosynostosis, characterized by acrocephaly with
no hand and foot involvement. Premature fusion of the coro-
nal sutures causes the acrocephaly, frontal bossing and flat
occipital bone. Looking at the face, there is hypoplasia of the
midline structures, reduced orbital volume and ocular prop-
tosis, strabismus, a small upturned nose, and maxillary hy-
poplasia. Fusions of cervical vertebrae and mild mental
retardation may occur. Crouzon syndrome may be due to dif-
ferent mutations of the FGFR2 gene with a wide range of
phenotypical expression. It may be sporadic, due to a de novo
mutation often related to advanced paternal age, or familiar
with autosomal dominant inheritance.
Muenke syndrome is a relatively frequent unilateral coro-
nal craniosynostosis with brachydactyly. It is caused by a mu-
tation (Pro250Arg) of the FGFR3 gene, with autosomal
dominant inheritance and variable clinical expression [16].
Most cases are familial, but unless there is an index case in
the family, the diagnosis may be missed in newborns with a
mild phenotype.
Pfeiffer syndrome is a rare acrocephalosyndactyly caused
by several mutations in FGFR1 and FGFR2 genes, with au-
tosomal dominant inheritance and variable clinical expressiv-
ity. Premature fusion of the coronal sutures causes
acrocephaly, frontal bossing and flat occipital bone. Con-
comitant synostosis of sagittal and lambdoideal sutures may
cause a cloverleaf appearance of the skull. The face is char-
acterized by downslanting palpebral fissures, ocular propto-
sis, strabismus, hypertelorism, maxillary hypoplasia, and
low-set ears. Hands and feet usually show hypoplasia of the
first ray (large first finger and toe, trapezoidal toe) and various
degree of postaxial syndactyly. There may be associated
elbow ankylosis or synostosis and vertebral fusions. Most se-
verely affected patients require early surgical correction to
prevent CNS complications. The prognosis is related to the
degree of phenotypical expression.
6.9.1.3 Treacher-Collins Syndrome (Franceschetti
Syndrome)
This syndrome is characterized by a developmental defect of
jaw and facial bones. There is wide variability. It is deter-
mined by several different mutations in the gene encoding the
treacle protein, which has a key role in early craniofacial de-
velopment [17].
Neonatal features are downslanting palpebral fissures,
palpebral coloboma, malar hypoplasia, macrostomia, microg-
nathia, external ear hypoplasia with atresia of the middle ear
and hearing loss. Cleft palate and choanal atresia may also be
present. In the most severely affected patients, there may be
impaired nutrition and respiratory function. Growth and psy-
chomotor development are usually normal, but affected chil-
dren need long-term multidisciplinary follow-up. Hearing
loss requires early treatment to preserve speech development.
Surgical treatment may correct bony defects and achieve use-
ful functional and aesthetic advantages.
6.9.1.4 Nager Syndrome (Acrofacial Dysostosis
Nager Type)
A sporadic condition with genetic heterogeneity (both auto-
somal dominant and autosomal recessive inheritance have
been described). Patients have a mandibulofacial dysostosis
with associated preaxial limb abnormalities (Fig. 6.10). The
mandibulofacial dysostosis is mainly characterized by micro-
cephaly, severe micrognathia and malar hypoplasia, low-set
posteriorly rotated ears and external auditory canal atresia.
The limb deformities consist of radial aplasia or hypoplasia,
radioulnar synostosis with limitation of elbow extension and
hypoplasia or absence of the thumbs.
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Fig. 6.9 Baby with Apert syndrome showing acrocephaly, frontal boss-
ing, exophthalmus, small upturned nose, maxillary hypoplasia, spoon
shaped hands
6.9.2 Thoraco-vertebral Dysostoses
Klippel-Feil anomaly is a developmental defect of the spine,
with possible changes at cervical, thoracic and/or lumbar
level (short neck, pterygium, kyphosis, scoliosis). X-ray in-
vestigation of the spine is required to show vertebral changes
(fusions, hemivertebrae, hemispondyls) and complete the di-
agnostic work-up – there are three clinical variants. It is more
frequent in females. Its etiology is heterogeneous, with ge-
netic and environmental (vascular disruptions) causes. It may
also be part of a more complex phenotype (cervico-oculo-
acoustic syndrome, MURCS association).
6.9.3 Limb Dysostoses
Digital defects are caused by a differentiation defect of one
or more contiguous bones. Digital development is determined
by a complex genetic system, which is phylogenetically com-
mon to most vertebrates. Digital anomalies may be sporadic
or familial with Mendelian inheritance, and may be associated
with other digital defects (polysyndactyly) and other syn-
dromic defects. 
Polydactyly may be defined as the presence of one or
more supernumerary fingers or toes. It is termed as complete
if it involves all phalanges, partial if it involves only distal
phalanges (duplication). In the preaxial forms, the extra digit
is related to the thumb; in the postaxial forms it is related to
the little finger.
Syndactyly is the fusion of two or more digits: it may in-
volve only skin and muscle or include the bones. In the most
severe cases, it may affect all the fingers of the limb causing
a “spoon” appearance. Symphalangism is the fusion of one or
more phalanges in the same digit, with severe ankylosis of
the interphalangeal joint.
Brachydactyly is the shortening of a digit due to develop-
mental defect of one or more phalanges. It is often associated
with metacarpal or metatarsal hypoplasia.
Ectrodactyly is a severe developmental anomaly of the
median axis of the hand or foot causing a “lobster claw” ap-
pearance. It is usually caused by a genetic etiology and may
be associated with other malformations (e.g., ectodermal de-
fects and cleft palate in the ectrodactyly-ectodermal dyspla-
sia-cleft syndrome [EEC syndrome]).
Oligodactyly is the absence or severe hypoplasia of one
or more digital axes. It may be preaxial or postaxial and is
frequently associated with other defects.
6.10 Osteochondrodysplasias 
A wide and heterogeneous group of genetically determined
conditions, involving the development and growth of bony
and cartilaginous tissues. The bone involvement is often pre-
natally diagnosed, although some cases become evident after
birth. The overall prevalence at birth is about 1/5000. There
has been a significant reduction in recent years because of ul-
trasonographic prenatal diagnosis of the most severe condi-
tions. The classification of osteochondrodysplasias, based on
phenotype, has recently been modified by advances in mo-
lecular genetics applied to genes involved the the synthesis
of collagen and elastin, fibroblast growth factor receptors,
cartilaginous proteins, vitamin D – receptor complex, lyso-
somal and peroxisomal enzymes.
Lethal osteochondrodysplasias are characterized by death
during the perinatal period because of generalized involve-
ment including long bones, spine and cranial bones. Mortality
is mainly related to respiratory failure (due to skeletal abnor-
malities and lung hypoplasia) and associated visceral and
CNS malformations. Milder osteochondrodysplasias (with
normal life expectancy, short stature and abnormal bone de-
velopment) may benefit from surgical bone elongation and
other corrective surgery and rehabilitation programs.
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Fig. 6.10 Baby with Nager syndrome showing microcephaly, microg-
nathia, malar hypoplasia and preaxial limb reduction defects
6.10.1 Achondroplasia
This is the most common cause of disproportionate short
stature with short limbs, determined by a heterozygous muta-
tion (Gly380Arg) of the FGFR3 gene at 4p16.3. It is inherited
as an autosomal dominant trait with a high rate of de novo mu-
tations (80−90% of patients), and is related to advanced pa-
ternal age. The recurrence risk is low if parents are not
affected. The phenotype at birth (Fig. 6.11) is characteristic:
megalencephaly, frontal bossing, depressed nasal bridge, facial
bone hypoplasia, prognatism, narrow thorax, rhizomelic short
limb dwarfism, brachydactyly, trident hands, hypotonia. Psy-
chomotor development is normal. Patients frequently develop
severe orthopaedic complications (lumbar hyperlordosis). In
some cases CNS complications, such as the cord compressions
and hydrocephalus, may occur during childhood.
6.10.2 Thanatophoric Dwarfism
A severe bone dysplasia with high perinatal lethality, due to
a heterozygous mutation of the FGFR3 gene at 4p16.3. All
patients are sporadic and due to de novo autosomal dominant
mutations. The phenotype is characterized by severe mi-
cromelic dwarfism with bowing and deformations of long
bones, “telephone receiver” femurs, narrow thorax, severe
platyspondyly (flattening of the vertebral bodies), facial bone
hypoplasia, craniosynostosis.
6.10.3 Camptomelic Dwarfism
A severe autosomal recessive bone dysplasia with high peri-
natal lethality and female prevalence. Due to mutations in the
SOX9 gene at 17q24-25. The phenotype includes sex reversal
(female external genitalia with male chromosomes), macro-
cephaly, large fontanelles, broad depressed nasal root, microg-
nathia, short neck, pectus carinatum, short limb dwarfism,
talipes, anterior bowing of tibiae, poor ossification signs [18].
6.10.4 Diastrophic Dysplasia
A rare autosomal recessive condition due to mutations of the
SLC26A2 gene at 5q32-q33.1. The distinct morphologic ab-
normality of the growth plate consists of an irregular distri-
bution of degenerating chondrocytes in the resting cartilage
with areas of intracartilagenous ossification. Patients have
rhizomelic short limb dwarfism, bilateral clubbed foot, cystic
lesions of the pinnae with calcification of the cartilage, pre-
mature calcification of the costal cartilages, kyphoscoliosis,
hip contractures, cleft palate. The “hitchhiker” thumb is par-
ticularly characteristic and is due to a deformity of the first
metacarpal. Intelligence is normal. Short stature with skeletal
abnormalities becomes more marked with advancing age.
6.10.5 Pseudodiastrophic Dysplasia
An autosomal recessive condition described by Burgio in pa-
tients with a phenotype similar to diastrophic dysplasia but
with proximal phalangeal joint dislocation, normal first
metacarpal, platyspondyly, tongue-like lumbar vertebral de-
formities, marked lumbar lordosis without cystic deformity of
the helix. The histologic appearance is different from dias-
trophic dysplasia and no SLC26A2 mutations have been
demonstrated. Most patients die during the first months of life.
6.10.6 Osteogenesis Imperfecta
A genetically and phenotypically heterogeneous group of
conditions characterized by frequent bone fractures [19].
Most frequently affected genes are those encoding for type 1
collagen (COL1A1 on 17q21-q22 and COL1A2 on 7q22)
with autosomal dominant (AD) and autosomal recessive
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Fig. 6.11 Neonatal achondroplasia with rhizomelic short limb
dwarfism, megalencephaly, frontal bossing, facial bone hypoplasia, nar-
row thorax
(AR) inheritance. Four different clinical variants have been
differentiated, but only type II and type III present at birth
with a severe phenotype and high perinatal lethality:
• type I (AD, triangular face, blue sclerae, otosclerosis with
secondary hearing loss, mitral valve prolapse, macro-
cephaly, joint hyperlaxity, possible dental abnormalities);
• type II (AD/AR, ossification deficiency, craniotabes,
pseudohydrocephalic skull, micrognathia, small nose,
blue sclerae, cardiac valve degeneration, endocardic and
aortic microcalcifications, multiple dental abnormalities);
• type III (AD/AR, blue sclerae, hydrocephalus, cortical at-
rophy, joint hyperlaxity, shortness and bowing of limbs,
possible dental abnormalities);
• type IV (AD, macrocephaly, frontal bossing, hearing loss,
joint hyperlaxity, osteoporosis, mild long bone deforma-
tions, possible dental abnormalities).
6.10.7 Osteodysplastic Primordial Dwarfism
A group of brachymelic microcephalic dwarfisms with likely
genetic heterogeneity and autosomal recessive inheritance.
Different clinical variants have been described in patients
with a prenatal onset of severe dwarfism (Fig. 6.12), micro-
cephaly, delayed closure of fontanelles, prominent eyes and
strabismus, microretrognathia, pointed nose, high arched
palate, oligodontia, small low-set dysplastic ears, sparse scalp
hair, pectus carinatum, delayed bone age, severe osteoporosis,
multiple skeletal abnormalities (hip dislocation, coxa vara,
joint contractures, short bowed long bones, small proximal
femoral epiphyses, thin diaphyses of long bones, brachy-
dactyly, talipes). Postnatal failure to thrive, mental retarda-
tion, sensory defects are consistently present during growth.
Life expectancy is reduced.
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Fig. 6.12 Patient with osteodysplastic primordial dwarfism with micro-
cephaly, severe shortness and deformations of long bones, redundant
skin folds at limbs
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